Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology
Multivariate Prediction of Hippocampal Atrophy in Alzheimer's Disease - IOS Press
31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part two | Journal for ImmunoTherapy of Cancer
Top Riders : Love to Ride UK
Liquid biopsy in the era of immuno-oncology: is it ready for prime-time use for cancer patients? - Annals of Oncology
Neuroimaging Feature Terminology: A Controlled Terminology for the Annotation of Brain Imaging Features - IOS Press
WO2004013347A2 - Methods of identifying compounds that modulate protein activity - Google Patents
Multivariate Prediction of Hippocampal Atrophy in Alzheimer's Disease - IOS Press
Resilience to cognitive impairment in the oldest-old: design of the EMIF-AD 90+ study | BMC Geriatrics | Full Text
Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology
Multimeric single-domain antibody complexes protect against bunyavirus infections | eLife
A highly potent antibody effective against SARS-CoV-2 variants of concern - ScienceDirect
Frontiers | Memory Clinics and Day Care Centers in Thessaloniki, Northern Greece: 30 Years of Clinical Practice and Experience | Neurology
Moto-Torq Remapping - पोस्टहरू | Facebook
Preclinical Alzheimer's disease: Definition, natural history, and diagnostic criteria - Dubois - 2016 - Alzheimer's & Dementia - Wiley Online Library
WO2004013347A2 - Methods of identifying compounds that modulate protein activity - Google Patents
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology
The EMIF-AD Multimodal Biomarker Discovery study: design, methods and cohort characteristics | Alzheimer's Research & Therapy | Full Text
Relevance of the interplay between amyloid and tau for cognitive impairment in early Alzheimer's disease - ScienceDirect
Clinical and biomarker profiling of prodromal Alzheimer's disease in workpackage 5 of the Innovative Medicines Initiative PharmaCog project: a 'European ADNI study' - Galluzzi - 2016 - Journal of Internal Medicine - Wiley Online Library
Frontiers | T-Cell Dependent Immunogenicity of Protein Therapeutics Pre-clinical Assessment and Mitigation–Updated Consensus and Review 2020 | Immunology
Partners — MELLODDY
WO2004013347A2 - Methods of identifying compounds that modulate protein activity - Google Patents
